Business
Crystal Bank Developments
Crystal Bank Developments.
About this update from Sareum Holdings Plc
[{"type":"text","content":"\n Sareum Holdings PLC\n24 November 2005\n\n\nFor immediate release 24 November 2005\n\n\n SAREUM HOLDINGS PLC\n\n\n (\"Sareum\" or \"The Company\")\n\n Success with Crystal Bank Protein Structure Resource\n\nSareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery\nand services business, is pleased to announce the latest developments with its\n\"Crystal Bank\" resource of rapidly accessible protein structures first announced\nin September 2005.\n\nTo date, Sareum has signed three fee-for-service collaborations involving\nCrystal Bank proteins, providing an important source of revenues to support its\nin-house research programs.\n\nSareum's Crystal Bank now comprises 16 therapeutically relevant proteins which\nare the targets for research into many important diseases including cancer,\ninflammation and metabolic disorders. Example structures include GSK3 beta, p38\nMAP kinase, CDK2/Cyclin A2, Zap-70, Erk2 and PPAR delta.\n\nCrystal Bank protein structures are available to pharmaceutical and\nbiotechnology company clients in complex with their potential drug candidates on\na fee-for-service basis. This information assists clients in accelerating their\ndrug discovery by providing a valuable insight into the precise nature of the\ninteraction between these potential drug candidates and their target proteins.\n\nCommenting on the announcement, Sareum's Chief Executive Officer, Dr Tim\nMitchell, said: \"We are extremely pleased to announce this growing list of\navailable protein structures and the commercial results achieved so far. This\nsuccess demonstrates our expertise in rapidly providing novel and valuable\nprotein structural information that will advance research into novel drug\ntreatments.\"\n\nFor further information:\n\nSareum Holdings 01223 497700\nTim Mitchell, Chief Executive Officer\n\nBuchanan Communications 020 7466 5000\nTim Anderson, Mary-Jane Johnson\n\nNotes for editors:\n\nAbout Crystal Bank\n\nSareum's Crystal Bank is a highly valuable resource for clients requiring fast\nturnaround of structural data that shows how their compounds bind with selected\nprotein targets. Such information accelerates the validation and selection of\nnovel lead compounds and is therefore invaluable at both the hit-to-lead and the\nlead optimisation stages of drug discovery research.\n\nCrystal Bank is a unique ...